Insider Trading & Ownership - MEANWELL CLIVE

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for MEANWELL CLIVE
Common stock purchase or sale:
Transaction
Date		Reported
DateTime		CompanySymbolInsider
Relationship		Shares
Traded		Average
Price		Total
Amount		Shares
Owned		Filing
2021-08-24
Purchase		2021-08-25
9:21 pm		Population Health Investment Co. Inc.PHICMEANWELL CLIVE
Chief Executive Officer		16,400$9.7969$160,66931,300
(Direct)		View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2024-02-06
Conversion		2024-02-08
4:40 pm		N/A
N/A		Fractyl Health Inc.GUTSMEANWELL CLIVE
Director		874,242$0277,890
(Indirect)		View
2024-02-01
Option Award		2024-02-05
5:10 pm		N/A
2034-01-31		Fractyl Health Inc.GUTSMEANWELL CLIVE
Director		45,000$045,000
(Direct)		View

Ownership		2024-02-01
6:18 pm		N/A
N/A		Fractyl Health Inc.GUTSMEANWELL CLIVE
Director		0$0277,890
(Indirect)		View
2023-11-09
Disposition		2023-11-09
4:06 pm		N/A
2030-10-13		EQRx Inc.EQRXMEANWELL CLIVE
Director		457,682$00
(Direct)		View
2023-05-23
Option Award		2023-05-25
6:42 pm		N/A
2033-05-22		Invivyd Inc.IVVDMEANWELL CLIVE
Director		50,000$050,000
(Direct)		View
2023-01-01
Option Award		2023-01-04
9:53 pm		N/A
2024-12-17		EQRx Inc.EQRXMEANWELL CLIVE
Director		226$043,172
(Direct)		View
2022-09-30
Option Award		2022-10-04
8:07 pm		N/A
2032-09-30		EQRx Inc.EQRXMEANWELL CLIVE
Director		101,010$0101,010
(Direct)		View
2022-06-22
Option Award		2022-06-24
5:01 pm		N/A
2032-06-21		Adagio Therapeutics Inc.ADGIMEANWELL CLIVE
Director
10% Owner		150,000$0150,000
(Direct)		View

Ownership		2022-03-30
9:57 pm		N/A
N/A		Adagio Therapeutics Inc.ADGIMEANWELL CLIVE
See Explanation of Responses.		0$01,201,680
(Indirect)		View
2021-12-17
Option Award		2021-12-20
9:56 pm		N/A
2030-10-13		EQRx Inc.EQRXMEANWELL CLIVE
Director		356,446$0356,446
(Direct)		View
2020-01-06
Disposition		2020-01-06
1:28 pm		N/A
N/A		MEDICINES COMDCOMEANWELL CLIVE
Chief Innovation Officer		1,994,034$00
(Direct)		View
2019-12-27
Exercise		2019-12-31
7:54 pm		2014-03-19
2020-02-19		MEDICINES COMDCOMEANWELL CLIVE
Chief Innovation Officer		541,671$0600,340
(Direct)		View
2019-12-27
Exercise		2019-12-31
7:54 pm		N/A
N/A		MEDICINES COMDCOMEANWELL CLIVE
Chief Innovation Officer		60,000$7.31600,340
(Direct)		View
2019-12-27
Exercise		2019-12-31
7:54 pm		N/A
N/A		MEDICINES COMDCOMEANWELL CLIVE
Chief Innovation Officer		15,620$13.54600,340
(Direct)		View
2019-12-27
Exercise		2019-12-31
7:54 pm		N/A
N/A		MEDICINES COMDCOMEANWELL CLIVE
Chief Innovation Officer		64,568$31.49600,340
(Direct)		View
2019-12-27
Exercise		2019-12-31
7:54 pm		N/A
N/A		MEDICINES COMDCOMEANWELL CLIVE
Chief Innovation Officer		11,483$30.55600,340
(Direct)		View
2019-12-27
Tax Withholding		2019-12-31
7:54 pm		N/A
N/A		MEDICINES COMDCOMEANWELL CLIVE
Chief Innovation Officer		352,141$84.78600,340
(Direct)		View
2019-12-27
Exercise		2019-12-31
7:54 pm		N/A
N/A		MEDICINES COMDCOMEANWELL CLIVE
Chief Innovation Officer		240,000$17.45600,340
(Direct)		View
2019-12-27
Exercise		2019-12-31
7:54 pm		N/A
N/A		MEDICINES COMDCOMEANWELL CLIVE
Chief Innovation Officer		150,000$22.04600,340
(Direct)		View
2019-08-30
Option Award		2019-09-04
4:21 pm		N/A
N/A		MEDICINES COMDCOMEANWELL CLIVE
Chief Innovation Officer		491$21.6290,810
(Direct)		View